QA: Rallybio Corp in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001739410_2023_Rallybio_Corp.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001739410, Rallybio Corp

  xvar xval
0 AssetsCurrent 179,496,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 385,000
3 remainder_Assets 554,000
4 LiabilitiesCurrent 10,744,000
5 LiabilitiesNoncurrent 374,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 27,195,000
9 ResearchAndDevelopmentExpense 40,689,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 1,230,000
13 remainder_ComprehensiveNetIncome -214,000
  yvar yval
0 Assets 180,435,000
1 Liabilities 11,118,000
2 Expenses 67,884,000
3 Revenues 0
4 StockholdersEquity 169,317,000
5 NetIncome -66,654,000
6 ComprehensiveNetIncome -66,761,000
7 BaseVar 130,440,500
8 EconomicCapitalRatiobeforeLimitedLiability 3.16
9 EconomicCapitalRatio 3.79

Edgar->Model Mapping

Feature Distribution